Discover Nandini Piramal's Impact in Consumer Healthcare and Piramal Pharma's Ambitious Journey

Leadership in Consumer Healthcare

Nandini Piramal plays a crucial role as the Executive Director of Piramal Enterprises Limited, steering the company into becoming a leader in consumer healthcare. Under her leadership, Piramal Pharma is targeting USD 2 billion in revenue by 2030, focusing on contract development and manufacturing, complex hospital generics, and consumer healthcare.

Growth Strategies

Piramal Pharma is leveraging its strengths in the Contract Development and Manufacturing Organization (CDMO) segment, especially with its Antibody-Drug Conjugate (ADC) platform, as a prominent growth driver for the future.

Notable Achievements

Nandini played an essential role in the sale of Piramal Healthcare's branded generic-medicine business to Abbott Laboratories, achieving a record 30x EBITDA. She also leads the Human Resources and Information Technology divisions at the Piramal Group.

Education and Recognition

With a Master's degree in Business Administration from Stanford and a Bachelor's in Politics, Philosophy, and Economics from Oxford, Nandini's credentials are impressive. She has been recognized as one of India’s Most Powerful Women by Business Today and named a 'Young Global Leader' by the World Economic Forum.

Nandini Piramal’s Financial Background

While Nandini Piramal's exact net worth isn't publicly disclosed, her family's substantial wealth, with her father Ajay Piramal being a prominent billionaire, underscores her position within this influential family.